News
Inovimbisa Mibairo yeCD7 CAR-T Therapy Yakasanganiswa neChipiri Kudyarwa muKudzoreredzwa T-ALL/LBL Varwere
Ongororo ichangoburwa inoratidza kushanda kweCD7 CAR-T therapy inoteverwa neyechipiri allogeneic hematopoietic stem cell transplantation (HSCT) muvarwere vane relapsed T-cell acute lymphoblastic leukemia (T-ALL) uye lymphoblastic lymphoma (LBL), inoratidza kugona kwakakosha kuwana zvishoma zvakasara chirwere (MRD) -negative kuregererwa kwakakwana.
Kushanda Kwenguva Yakareba kweCD19 CAR T-Cell Therapy muKurapa Yakadzokazve / Refractory Acute Lymphoblastic Leukemia
Chidzidzo chepasi chinoratidza kubudirira kwenguva refu kweCD19 CAR T-cell therapy mukurapa varwere vane relapsed/refractory acute lymphoblastic leukemia (ALL) zvichitevera allogeneic hematopoietic stem cell transplantation, ichipa tariro itsva muhematology.
Bioocus Inosimudzira Muganho muKurapa Pediatric Acute Lymphoblastic Leukemia
Bioocus iri pamberi mukugadzira chizvarwa chinotevera cheCAR-T marapirwo. Chinyorwa chazvino chakaitwa naDr. Chunrong Tong nechikwata chake pachipatara cheLu Daopei chinoratidza kufambira mberi kwakanyanya uye matambudziko mukushandiswa kwechizvarwa chechipiri cheCD19 CAR-T kurapwa muvarwere vevana, zvichiratidza kuzvipira kwaBiocus pakurapa kenza.
Kupayona CAR-T Therapy muB-cell Acute Lymphoblastic Leukemia Inoratidza Kubudirira Kusati Kwamboitika
Chidzidzo chepasi chinosimbisa kushanda kunoshamisa kweCAR-T cell therapy mukurapa B-cell Acute Lymphoblastic Leukemia (B-ALL). Tsvagiridzo iyi, inosanganisira kubatana neBIOOCUS neLu Daopei Hospital, inoratidza kufambira mberi kwakakosha, kutanga kurapwa senzira yakakosha yekurapa.
Innovative CAR-T Cell Therapies Shandura Kurapa kweB Cell Malignancies
Vatsvagiri vanobva kuLu Daopei Hospital uye vanobatana nedzimwe nyika vanoongorora nzira dzekurapa dzeCAR-T cell, zvichipa tariro kune varwere vane B cell malignancies. Ichi chidzidzo chinosimbisa kufambira mberi mukugadzira nekushandisa, kuratidza mhedzisiro inovimbisa uye mukana wezvitsva zveramangwana.
Kuwedzera Antitumor Kubudirira kwe4-1BB-Yakavakirwa CD19 CAR-T Masero muKurapa B-ALL
Zvichangoburwa zvidzidzo zvekiriniki zvinoratidza kuti 4-1BB-based CD19 CAR-T masero anoratidza hukuru hweantitumor efficacy kana ichienzaniswa neCD28-based CAR-T masero mukurapa kudzokazve kana refractory B cell acute lymphoblastic leukemia (r/r B-ALL).
Chipatara cheLu Daopei's Low-Dose CD19 CAR-T Therapy Inoratidza Mibairo Inovimbisa muB-ALL Varwere
Ongororo ichangoburwa pachipatara cheLu Daopei yakaratidza kushanda kwepamusoro uye kuchengetedzeka kweyepasi-dose CD19 CAR-T cell therapy mukurapa refractory kana kudzokazve B acute lymphoblastic leukemia (B-ALL) varwere. Tsvakurudzo, iyo yaisanganisira varwere ve51, yakaratidza chiyero chinoshamisa chekuregererwa nemigumisiro shoma.
Novel Promoter Strategy Inovandudza Kuchengetedzeka uye Kushanda kweCAR-T Therapy muAcute B Cell Leukemia.
Chipatara cheLu Daopei neHebei Senlang Biotechnology vazivisa zvinovimbisa zvakawanikwa kubva muongororo yavo yazvino pamusoro pekuchengetedza uye kushanda kweCAR-T kurapwa kweacute B cell leukemia. Kudyidzana uku kunotaridza kugona kwenovel CAR-T masero magadzirirwo ekusimudzira mhedzisiro yemurwere.
Kubudirira Kudzidza Kunoratidza Kuchengetedzeka uye Kushanda KweCAR-T Therapy muKurapa B-Cell Malignancies.
Chidzidzo chitsva chinotungamirwa naDr. Zhi-tao Ying kubva kuPeking University Cancer Hospital yakaratidza kuchengetedzwa uye kushanda kweIM19 CAR-T cell therapy mukurapa kudzokazve uye kudzoreredza B-cell hematologic malignancies. Rakadhindwa muChinese Journal of New Drugs, chidzidzo chinoshuma kuti 11 kubva kuvarwere ve12 vakawana kuregererwa kwakakwana pasina migumisiro yakaipisisa, kuratidza kukwanisa kweIM19 sechivimbiso chekurapa kusarudzwa kune varwere vane dzimwe nzira dzisina kukwana.
Kubudirira Kufambira mberi muMuurayi Wepanyama (NK) Masero Anopfuura 50 Makore
Kwemakumi mashanu emakore apfuura, tsvakiridzo yeMasikirwo Muurayi (NK) masero akashandura manzwisisiro edu ekusagadzikana kwemukati, achipa nzira nyowani dzegomarara nehutachiona.
Gore negore Clinical Blood Management uye Transfusion Technology Training Yakaitwa paYanda Ludaopei Hospital
Iyo 2024 Yepagore Kudzidziswa kweClinical Ropa Management uye Transfusion Tekinoroji muSanhe City yakaitwa zvakabudirira paYanda Ludaopei Hospital. Chiitiko ichi chine chinangwa chekusimudzira manejimendi eropa rekiriniki uye kuchengetedzwa kwekuwedzerwa ropa kuburikidza nemisangano yakazara yekudzidziswa inopindwa nevanopfuura zana vezvehutano vehutano kubva kumasangano akasiyana ekurapa.
Kubudirira muPediatric Autoimmune Disease: CAR-T Cell Therapy Inorapa Lupus Murwere
Chidzidzo chekupayona paErlangen University Hospital zvakabudirira kubata musikana wemakore gumi nematanhatu ane chirwere chakanyanya systemic lupus erythematosus (SLE) achishandisa CAR-T cell therapy. Izvi zvinoratidza kushandiswa kwekutanga kwekurapa uku kwevana lupus, zvichipa tariro nyowani kuvana vane autoimmune zvirwere.